These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16843673)

  • 1. Studies of interactions between uracil-based hybrid molecules and P-glycoprotein--search for multidrug resistance modulators.
    Singh P; Paul K
    Bioorg Med Chem; 2006 Nov; 14(21):7183-6. PubMed ID: 16843673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators.
    Singh P; Paul K; Holzer W
    Bioorg Med Chem; 2006 Jul; 14(14):5061-71. PubMed ID: 16554161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for MDR modulators: design, syntheses and evaluations of N-substituted acridones for interactions with p-glycoprotein and Mg2+.
    Singh P; Kaur J; Kaur P; Kaur S
    Bioorg Med Chem; 2009 Mar; 17(6):2423-7. PubMed ID: 19243953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of highly functionalized barbituric acids and study of their interactions with p-glycoprotein and Mg2+--potential candidates for multi drug resistance modulation.
    Singh P; Kaur J; Bhardwaj A
    Eur J Med Chem; 2010 Mar; 45(3):1256-62. PubMed ID: 20053485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance.
    Boumendjel A; Di Pietro A; Dumontet C; Barron D
    Med Res Rev; 2002 Sep; 22(5):512-29. PubMed ID: 12210557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS; Thimmaiah P; Thimmaiah KN
    Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance.
    Schmidt M; Ungvári J; Glöde J; Dobner B; Langner A
    Bioorg Med Chem; 2007 Mar; 15(6):2283-97. PubMed ID: 17276076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.
    Klinkhammer W; Müller H; Globisch C; Pajeva IK; Wiese M
    Bioorg Med Chem; 2009 Mar; 17(6):2524-35. PubMed ID: 19250834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships.
    Chan KF; Zhao Y; Chow TW; Yan CS; Ma DL; Burkett BA; Wong IL; Chow LM; Chan TH
    ChemMedChem; 2009 Apr; 4(4):594-614. PubMed ID: 19288491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of RNA helicase A by DNA-dependent protein kinase is indispensable for expression of the MDR1 gene product P-glycoprotein in multidrug-resistant human leukemia cells.
    Zhong X; Safa AR
    Biochemistry; 2007 May; 46(19):5766-75. PubMed ID: 17441731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
    Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
    Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH
    J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells.
    Ma Y; Wink M
    Phytomedicine; 2008 Sep; 15(9):754-8. PubMed ID: 18222670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sipholane triterpenoids: chemistry, reversal of ABCB1/P-glycoprotein-mediated multidrug resistance, and pharmacophore modeling.
    Jain S; Abraham I; Carvalho P; Kuang YH; Shaala LA; Youssef DT; Avery MA; Chen ZS; El Sayed KA
    J Nat Prod; 2009 Jul; 72(7):1291-8. PubMed ID: 19534474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.
    Jiménez-Alonso S; Pérez-Lomas AL; Estévez-Braun A; Muñoz Martinez F; Chávez Orellana H; Ravelo AG; Gamarro F; Castanys S; López M
    J Med Chem; 2008 Nov; 51(22):7132-43. PubMed ID: 18954040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
    Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
    In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.